Загрузка...
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis
BACKGROUND: Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm reduction program to control HCV. We aimed to describe the prevalence of HCV antibody (Ab) in Iranian PWID before and after the...
Сохранить в:
| Опубликовано в: : | Harm Reduct J |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7825164/ https://ncbi.nlm.nih.gov/pubmed/33482831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12954-020-00441-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|